United Kingdom Archives

wheat meiogenix spix epigenetics cambridge bbrsc

News and Trends 28 Apr 2016

French Biotech and Cambridge to improve Food Security with UK Grant

Meiogenix and the University of Cambridge will get fresh money to investigate how epigenomics impacts crop diversity – and how it can be engineered for better yields of wheat. Based in Paris, Meiogenix is developing breeding technologies – which already caught the eye of Bayer Crop Science. One of its platforms is SpiX, which increases the […]

April 28, 2016 - 2 minutesmins - By Denise Neves Gameiro

interview biotrinity labiotech dementia fund

News and Trends 28 Apr 2016

Interviewing the CSO of the newly €90M fund willing to finally tackle Dementia

I had the chance to talk with Tetsuyuki Maruyama, the CSO of the relatively new Dementia Discovery Fund – our final interview for #BioTrinity2016 in London. The high risk nature of doing trials for Dementia patients means in the past the market for this area of Neurodegenerative disease has been tough. However, the need for […]

April 28, 2016 - 1 minutemin - By Philip Hemme

bioviva ageing gene therapy telomerase parrish

News and Trends 25 Apr 2016

Anti-ageing DIY Gene Therapy may have worked – to an extent…

The weird tale of BioViva‘s CEO receiving non-approved gene therapy to fight ageing has developed further – now with ‘successful results’, which have been verified by two EU research NGOs. There may be something to it after all? Stopping ageing has always been a dream of mankind – and one that is slowly beginning to […]

April 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

astrazeneca centre genomics research hli wellcome fimm

News and Trends 25 Apr 2016

AstraZeneca partners up with Genomics Elite for new Biobank

AstraZeneca has announced it will create a new Centre for Genomics Research in Cambridge (UK) – joining the Wellcome Sanger, a Craig Venter Biotech and a Finnish specialist Institute to do so. AstraZeneca is betting on genomics to transform drug discovery and support its R&D pipeline. The idea is to create a ‘biobank‘ with genome analysis, integrated with data from […]

April 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

TC biopharm immunicell melanoma kidney cancer

News and Trends 25 Apr 2016

Scottish Biopharma begins Cell Therapy trials for Late-Stage Cancer

TC BioPharm has began recruitment to a phase II/III trial with its lead candidate (ImmuniCell), a T-cell therapy now targeting skin, lung and kidney cancer. Based in Scotland, TC BioPharm is developing cell-based therapies for cancer and severe viral infection. These therapies are based on γδ T-cells, which can recognise and target specific structures on the cell surface […]

April 25, 2016 - 2 minutesmins - By Denise Neves Gameiro

Katharine dowson bioart science gallery hiv brain malformation glass

News and Trends 23 Apr 2016

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

Represented by the GV Art Gallery in London, Katharine Dowson is a glass sculptor who is well established in the BioArt community as an Anatomical and medicine specialist. Katharine studied at the Royal College of Art and Camberwell in London, with a focus spanning to include the anatomical form (particularly the Nervous system) to infectious diseases and developmental research into a […]

April 23, 2016 - 4 minutesmins - By Dani Bancroft

cannabis cannabidiol gw pharmaceuticals tuberous sclerosis complex epilepsy biotech fda orphan drug trials

News and Trends 22 Apr 2016

UK Cannabis Biotech gets another Orphan Drug Designation by the FDA

Cambridge based GW Pharmaceuticals has now been granted Orphan Drug Designation from FDA for Cannabidiol drug to treat a 3rd rare genetic form of epilepsy. GW Pharmaceuticals has been granted Orphan Drug Designation for cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). Epidiolex is a liquid formulation of pure plant-derived CBD, which is in development for […]

April 22, 2016 - 2 minutesmins - By Dani Bancroft

stevenage biosciences catalyst catapult appolo MRC biotech

News and Trends 19 Apr 2016

Drug Discovery moves to Stevenage – the new Golden Triangle hotspot?

MRC Technology, a UK medical research charity, has moved most of its labs to the Stevenage Bioscience Catalyst (SBC) campus. Located inside the gold triangle, is this the new hotspot of UK Biotech? MRC Technology provides drug discovery services, as well as advice for commercialisation and intellectual property management, for academia and industry. Since it was founded […]

April 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

gsk morphosys hand osteoarthritis rheumatoid

News and Trends 19 Apr 2016

GSK goes to phase II with German Antibody for Inflammatory Diseases

GSK has started a phase II trial for inflammatory hand osteoarthritis, with a candidate originally from MorphoSys‘ antibody library. GSK, a big UK Pharma, has announced the start of a phase II study to evaluate the efficacy and safety of its candidate, GSK3196165. The trial will enroll 40 patients with hand osteoarthritis – a condition that damages […]

April 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

oxford biotherapeutics drug cancer boehringer

News and Trends 18 Apr 2016

UK Drug Discovery sells Cancer Target to German Pharma

Boehringer Ingelheim has bought exclusive rights to an oncology target discovered by Oxford BioTherapeutics and its proteomic database. Oxford BioTherapeutics is a Biotech in Milton Park (near Oxford, UK), developing immunotherapies for cancer with antibody-drug conjugates (ADC) – a strategy to combine the specificity of antibodies to a toxic agent that can be delivered to a cancerous cell. […]

April 18, 2016 - 2 minutesmins - By Denise Neves Gameiro

cellnovo biotech diabetes medtech device horizon2020

News and Trends 13 Apr 2016

Mobile Pancreas to Change Life of Diabetics in New EU Programme

A new €4M European project brings a mobile insulin pump from France, computer models from Romania, and research from the UK & Spain together, in order to improve living with diabetes. Cellnovo, a MedTech split between France and the UK, was selected to participate in a new diabetes project funded by Horizon 2020, the EU grant […]

April 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

lipigon astrazeneca lipoprotein lipase lpl cardiovascular

News and Trends 11 Apr 2016

Swedish Startup close to the North Pole signs 100 million deal with AstraZeneca

Lipigon Pharmaceuticals will now count with AstraZeneca to push the development of its Lipoprotein Lipase strategies. This could produce novel drugs to tackle metabolic and cardiovascular disease, still the leading cause of death worldwide. Lipigon is a spinout of Umeå University, developing new drugs based on research of lipid metabolism. Umeå may have one of the most remote universities […]

April 11, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

French Biotech and Cambridge to improve Food Security with UK Grant

Interviewing the CSO of the newly €90M fund willing to finally tackle Dementia

Anti-ageing DIY Gene Therapy may have worked – to an extent…

AstraZeneca partners up with Genomics Elite for new Biobank

Scottish Biopharma begins Cell Therapy trials for Late-Stage Cancer

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

UK Cannabis Biotech gets another Orphan Drug Designation by the FDA

Drug Discovery moves to Stevenage – the new Golden Triangle hotspot?

GSK goes to phase II with German Antibody for Inflammatory Diseases

UK Drug Discovery sells Cancer Target to German Pharma

Mobile Pancreas to Change Life of Diabetics in New EU Programme

Swedish Startup close to the North Pole signs 100 million deal with AstraZeneca

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!